RNS Number : 0005G
Cambridge Nutritional Sciences PLC
04 November 2025
 

 

Cambridge Nutritional Sciences plc

 

(the "Company" or "CNSL")

 

Notice of Results & Investor Presentation via Investor Meet Company

 

Cambridge Nutritional Sciences plc (AIM: CNSL), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, confirms it will issue its Half Year results for the six months ended 30 September 2025 on Monday 10 November 2025.

 

Investor Presentation:

 

On the same day at 16:00 BST, James Cooper (Chief Executive Officer) and Ajay Patel (Chief Financial Officer) will host a live online presentation via the Investor Meet Company ("IMC") platform to discuss the results.

 

The presentation is open to all existing and potential shareholders. Questions can be submitted in advance via the IMC dashboard up until 09:00 BST on 9 November 2025, or during the live event.

 

To register for the event and add Cambridge Nutritional Sciences plc to your watchlist, please visit:

https://www.investormeetcompany.com/cambridge-nutritional-sciences-plc/register-investor

 

Shareholders who already follow Cambridge Nutritional Sciences plc on the IMC platform will be automatically invited to the presentation.

 

 

Contacts: 

Cambridge Nutritional Sciences plc        

www.cnsplc.com

Carolyn Rand, Non-Executive Chair

[email protected]

James Cooper, Chief Executive Officer


Ajay Patel, Chief Financial Officer


 

Cavendish Capital Markets Limited    

 

Tel: 020 7220 0500

Geoff Nash / Edward Whiley (Corporate Finance)


Nigel Birks / Harriet Ward (ECM)






About Cambridge Nutritional Sciences plc

Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORUOOBRVWUARAA